| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
MAP4K5 |
MAP4K5: Mitogen-activated protein kinase kinase kinase kinase 5 |
2.63 |
Evidence |
|
| FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
2.63 |
Evidence |
|
| SKI |
SKI: Ski oncogene |
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
2.63 |
Evidence |
|
| RANBP2 |
RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 |
PICALM |
PICALM, CALM: Phosphatidylinositol-binding clathrin assembly protein |
2.63 |
Evidence |
|
| FZD7 |
FZD7: Frizzled-7 precursor |
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
2.63 |
Evidence |
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
JARID1A |
JARID1A, RBBP2, RBP2: Histone demethylase JARID1A |
2.63 |
Evidence |
|
| TAP1 |
IPI00101026 |
ABCD2 |
ABCD2, ALD1, ALDL1, ALDR, ALDRP: ATP-binding cassette sub-family D member 2 |
2.622 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
TCF3 |
IPI00216911 |
2.622 |
Evidence |
|
| KCNQ1 |
KCNQ1, KCNA8, KCNA9, KVLQT1: Potassium voltage-gated channel subfamily KQT membe |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.622 |
Evidence |
|
| BHLHB3 |
BHLHB3, DEC2, SHARP1: Class B basic helix-loop-helix protein 3 |
MYCL1 |
MYCL1, LMYC, MYCL: L-myc-1 proto-oncogene protein |
2.622 |
Evidence |
|
| HCN1 |
HCN1, BCNG1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
CACNA1D |
CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2: Voltage-dependent L-type calcium chann |
2.622 |
Evidence |
|
| BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
2.622 |
Evidence |
|
| MEFV |
IPI00375378 |
NALP5 |
NLRP5, MATER, NALP5: NACHT, LRR and PYD domains-containing protein 5 |
2.622 |
Evidence |
|
| NULL |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-33 alpha chain precursor |
CD1E |
CD1E, RP11-101J8.5-005, hCG_1640053: CD1e molecule |
2.622 |
Evidence |
|
| LARS2 |
LARS2, KIAA0028: Probable leucyl-tRNA synthetase, mitochondrial precursor |
PLXNB2 |
MM1: Clone MM1 product (Fragment) |
2.622 |
Evidence |
|
| GABRA1 |
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1 precursor |
GABRA4 |
GABRA4: Gamma-aminobutyric acid receptor subunit alpha-4 precursor |
2.622 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
NULL |
MHC class II HLA-SX-alpha gene. (Fragment) |
2.622 |
Evidence |
|
| TRPV4 |
IPI00657947 |
KCNA10 |
KCNA10, Kcn1, RP11-470L19.4-001, hCG_1647453: Potassium voltage-gated channel su |
2.622 |
Evidence |
|
| FES |
FES, FPS: Proto-oncogene tyrosine-protein kinase Fes/Fps |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
2.622 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
TESK2 |
TESK2: Dual specificity testis-specific protein kinase 2 |
2.622 |
Evidence |
|
| TCF12 |
TCF12, HEB, HTF4: Transcription factor 12 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BOK |
BOK: Bcl-2-related ovarian killer protein |
2.622 |
Evidence |
|
| TRPV3 |
IPI00555580 |
RYR2 |
RYR2: Ryanodine receptor 2 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
2.622 |
Evidence |
|
| BAX |
BAX: Apoptosis regulator BAX, cytoplasmic isoform beta |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
2.622 |
Evidence |
|
- 
- 
-